Latest News on USPH

Financial News Based On Company


Advertisement
Advertisement

USPH: Hospital affiliations lift reimbursement as demand and diversified growth engines expand

https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:4684649:0-usph-hospital-affiliations-lift-reimbursement-as-demand-and-diversified-growth-engines-expand/
U.S. Physical Therapy, Inc. (USPH) is expanding its outpatient physical therapy platform through hospital affiliations, acquisitions, and industrial injury prevention. This growth is supported by record clinic demand and a low leverage profile. Hospital programs contributed 13% to PT revenue in Q3, with expectations for an even higher contribution in Q4.

Form 8K US Physical Therapy Inc For: 17 November By Investing.com

https://ca.investing.com/news/stock-market-news/form-8k-us-physical-therapy-inc-for-17-november-93CH-4965223
This article reports on the filing of Form 8K by US Physical Therapy Inc. for November 17, 2026. The brief announcement provides no further details but indicates the company's regulatory disclosure. It also highlights the current stock performance of USPH.

Form 8K US Physical Therapy Inc For: 17 November By Investing.com

https://uk.investing.com/news/stock-market-news/form-8k-us-physical-therapy-inc-for-17-november-93CH-4988992
US Physical Therapy Inc. (USPH) filed a Form 8K on November 17, 2026. This SEC filing is a routine disclosure document used to report unscheduled material events or corporate changes at a company. The article, published by Investing.com, simply notes the filing without providing further details about its content.

COO Graham D. Reeve sells U.S. Physical Therapy (USPH) shares at a $99.42 average.

https://www.stocktitan.net/sec-filings/USPH/form-4-u-s-physical-therapy-inc-nv-insider-trading-activity-5ca206c5c464.html
U.S. Physical Therapy (USPH) COO Graham D. Reeve sold 1,792 shares of common stock on November 16, 2026, at a weighted average price of $99.42 per share. Prices for the multiple transactions ranged from $99.16 to $99.57. Following the sale, Reeve directly held 26,762 shares, including 17,488 restricted shares which will vest in installments through March 2030.

Form 4 US Physical Therapy Inc: Nchacha Etta (EVP & Chief Financial Officer) For: 14 September By Investing.com

https://in.investing.com/news/stock-market-news/form-4-us-physical-therapy-inc-nchacha-etta-evp--chief-financial-officer-for-14-september-93CH-5705565
This article reports on a Form 4 filing for US Physical Therapy Inc., noting that Nchacha Etta, the EVP & Chief Financial Officer, had a filing for September 14. Form 4 filings detail changes in beneficial ownership of company stock by corporate insiders. The brief piece indicates that USPH stock was up 1.01% at the time of publication.
Advertisement

Form 4 US Physical Therapy Inc: Nchacha Etta (EVP & Chief Financial Officer) For: 14 September

https://au.investing.com/news/stock-market-news/form-4-us-physical-therapy-inc-nchacha-etta-evp--chief-financial-officer-for-14-september-93CH-4772024
This article reports on a Form 4 filing for US Physical Therapy Inc, detailing a transaction by Nchacha Etta, EVP & Chief Financial Officer, related to September 14. The filing is presented without additional commentary or specific details about the transaction itself, serving primarily as a brief notification of the insider activity. The article highlights the company's stock symbol, USPH, and its recent performance.

Two entities report passive stakes above 5% in U.S. Physical Therapy (USPH).

https://www.stocktitan.net/sec-filings/USPH/schedule-13g-u-s-physical-therapy-inc-nv-passive-investment-disclosur-fd84d964c486.html
Neuberger Berman Group LLC and Neuberger Berman Investment Advisers LLC have each reported a 6.6% passive stake in U.S. Physical Therapy (USPH) as of September 30, 2026, through a Schedule 13G filing. Neuberger Berman Group LLC reported beneficial ownership of 980,468 shares, while Neuberger Berman Investment Advisers LLC reported 979,814 shares. Both entities disclaimed beneficial ownership, stating the shares are held in various fiduciary capacities for clients, with shared voting and dispositive powers.

Us physical therapy stock hits 52-week high at $101.36

https://www.investing.com/news/company-news/us-physical-therapy-stock-hits-52week-high-at-10136-93CH-5022275
US Physical Therapy Inc. (USPH) recently hit a 52-week high of $101.36, with its stock price increasing by 41.45% over the past year, reflecting strong performance and investor confidence. The company also reported robust third-quarter 2026 financial results, surpassing Wall Street expectations with adjusted earnings of $0.80 per share and revenue of $222.55 million. Despite being considered overvalued by InvestingPro, the company demonstrates resilience and potential for future growth in the healthcare sector.

We Wouldn't Be Too Quick To Buy U.S. Physical Therapy, Inc. (NYSE:USPH) Before It Goes Ex-Dividend

https://simplywall.st/stocks/us/healthcare/nyse-usph/us-physical-therapy/news/we-wouldnt-be-too-quick-to-buy-us-physical-therapy-inc-nyseu
U.S. Physical Therapy, Inc. (NYSE:USPH) is set to trade ex-dividend in four days, with the next payment being US$0.46 per share. While the company has been unprofitable, its dividend payment is covered by 40% of its free cash flow. The article suggests caution for investors due to declining earnings over the last five years and the company currently being loss-making, despite a 10% annual dividend increase over the last decade.

U.S. Physical Therapy hosts call to discuss Q3 and nine-month results

https://ca.investing.com/news/stock-market-news/us-physical-therapy-hosts-call-to-discuss-q3-and-ninemonth-results-93CH-4944388
U.S. Physical Therapy, Inc. (NYSE:USPH) hosted a conference call and webcast to discuss its financial results for the three and nine months ended September 30, 2026. The company's stock has seen significant gains, with a 17% increase over the past week and a 70% surge over six months, trading near its 52-week high. Despite a loss over the last twelve months, analysts forecast profitability for the current year with an EPS of $2.91, although InvestingPro analysis suggests the stock might be overvalued.
Advertisement

Form 8K US Physical Therapy Inc For: 9 November By Investing.com

https://ca.investing.com/news/stock-market-news/form-8k-us-physical-therapy-inc-for-9-november-93CH-4944385
This article from Investing.com announces the filing of a Form 8K by US Physical Therapy Inc. for November 9, 2026. The brief piece highlights this corporate filing as a news item relevant to the stock market.

U.S. Physical Therapy Reports 13% Q3 Revenue Growth, Reaffirms EBITDA Guidance

https://www.tradingview.com/news/tradingview:9a9bd8262bfc4:0-u-s-physical-therapy-reports-13-q3-revenue-growth-reaffirms-ebitda-guidance/
U.S. Physical Therapy (USPH) reported a 13% increase in third-quarter revenue, reaching $223 million, and reaffirmed its full-year EBITDA guidance between $102 million and $106 million. The company saw an 8% rise in physical therapy visits and a $5 increase in revenue per visit, largely due to hospital affiliations. Despite higher employee health benefit costs impacting PT margins, industrial injury prevention revenue grew by 14% with improved margins.

USPH: U.S. Physical Therapy Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

https://www.quantisnow.com/insight/us-physical-therapy-inc-filed-sec-form-8-k-regulation-fd-6781613
U.S. Physical Therapy Inc. (USPH) filed an SEC Form 8-K, reporting third-quarter 2026 results. The company saw a 13% rise in total revenue to $223 million and reaffirmed its full-year EBITDA guidance, with adjusted EPS at $0.80. Despite a GAAP loss per share of $1.04 due to changes in partner ownership stakes, mature clinic revenue grew by 6%, and Industrial Injury Prevention margin increased.

U.S. Physical Therapy, Inc. (USPH) Seasonal returns chart

https://uk.finance.yahoo.com/quote/USPH/seasonality/
U.S. Physical Therapy, Inc. (USPH) stock closed at $98.60 with a -1.50% change. The company announced a cash dividend of $0.46 with an ex-date of November 16, 2026. The article also includes historical seasonality data showing average monthly price returns from 2016 to 2026.

U.S. Physical Therapy Q3 Earnings Call Highlights

https://www.tradingview.com/news/marketbeat:7fcf6c53c094b:0-u-s-physical-therapy-q3-earnings-call-highlights/
U.S. Physical Therapy (USPH) reported strong double-digit revenue and EBITDA growth for Q3 2026, driven by increased patient volumes and higher reimbursement rates from new hospital affiliations. The company reaffirmed its full-year EBITDA guidance, despite facing rising employee health costs. Management plans to continue pursuing tuck-in acquisitions, new clinics, and additional hospital partnerships.
Advertisement

US Physical Therapy Q3FY26 Results: Revenue up 13%, EBITDA grows 16%

https://scanx.trade/stock-market-news/companies/us-physical-therapy-q3fy26-results-revenue-up-13-ebitda-grows-16/55448822
US Physical Therapy reported a 13% increase in total revenue to $223 million for Q3 FY26, driven by 8% volume growth and higher reimbursement rates from new hospital partnerships. EBITDA grew by 16% to $28 million, despite pressure from elevated self-insured employee health costs. The company reaffirmed its full-year EBITDA guidance of $102 million to $106 million, anticipating continued growth from hospital affiliations and industrial injury prevention.

USPH: Hospital affiliations and stronger PT volume drove double-digit Q3 growth; FY EBITDA guidance held

https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:4477162:0-usph-hospital-affiliations-and-stronger-pt-volume-drove-double-digit-q3-growth-fy-ebitda-guidance-held/
U.S. Physical Therapy, Inc. (USPH) reported strong Q3 2026 results with revenue growing 13% and EBITDA rising over 16%, primarily driven by increased physical therapy volume and hospital affiliations. Despite elevated employee health costs impacting margins, the company reaffirmed its full-year EBITDA guidance of $102 million-$106 million.

US Physical Therapy Inc (USPH) (Q3 2026) Earnings Call Highlights: Record Visits and Revenue ...

https://ca.finance.yahoo.com/news/us-physical-therapy-inc-usph-232537788.html
US Physical Therapy Inc (USPH) reported record patient visits for 27 consecutive months and a 13% increase in total revenue to $223 million in Q3 2026. The company achieved a record net rate per visit of $112, driven by hospital affiliations and improved payer mix. Despite these gains, self-insured group health costs negatively impacted PT margins, and the company reported a GAAP loss per share of $1.04 due to changes in redeemable non-controlling interest.

US Physical Therapy Q3 2026 Earnings Call Transcript

https://www.benzinga.com/news/26/11/62936224/us-physical-therapy-q3-2026-earnings-call-transcript
US Physical Therapy reported a 13% increase in Q3 2026 total revenue, driven by an 8% growth in physical therapy visits and higher reimbursement rates from hospital affiliations. EBITDA grew over 16%, despite higher self-insured employee health costs, and the company reaffirmed its full-year EBITDA guidance of $102 million to $106 million. Strategic initiatives like new hospital partnerships, de novo clinics, and acquisitions, alongside cost control measures, are expected to drive future growth and margin improvement.

U.S. Physical Therapy (NYSE:USPH) reports strong Q3 2026

https://www.tradingview.com/news/stockstory:648e38fda094b:0-u-s-physical-therapy-nyse-usph-reports-strong-q3-2026/
U.S. Physical Therapy (NYSE:USPH) reported strong Q3 2026 results, with revenue up 12.9% year-on-year to $222.6 million, exceeding Wall Street expectations. Non-GAAP profit of $0.80 per share also beat consensus estimates by 10.3%. The company's chairman and CEO, Chris Reading, attributed the EBITDA improvement to the initial benefits of new hospital affiliations.
Advertisement

(USPH) Risk Channels and Responsive Allocation

https://news.stocktradersdaily.com/news_release/16/USPH_Risk_Channels_and_Responsive_Allocation_110426025002_1793778602.html
U.s. Physical Therapy Inc. (NASDAQ: USPH) is showing a mid-channel oscillation pattern with weak near-term sentiment, potentially leading to bearish positioning. An exceptional short setup offers a 37.7:1 risk-reward ratio, targeting a 10.8% downside against 0.3% risk. AI models have generated three distinct trading strategies—Position Trading (Long), Momentum Breakout (Breakout), and Risk Hedging (Short)—each designed with specific entry, target, and stop-loss parameters tailored to different risk profiles.

U.S. Physical Therapy (USPH) reports earnings tomorrow: what to expect

https://markets.financialcontent.com/stocks/article/stockstory-2026-11-3-us-physical-therapy-usph-reports-earnings-tomorrow-what-to-expect
U.S. Physical Therapy (USPH) is scheduled to report earnings this Wednesday after market close. Analysts expect revenue to grow by 8.7% year-on-year, a slowdown from the 17.3% growth in the same quarter last year. The company has a history of rarely missing Wall Street's revenue estimates, and investor sentiment in the healthcare providers & services segment has been positive recently.

Vanguard Capital Management reports sole voting power over 113,696 US Physical Therapy (USPH) shares.

https://www.stocktitan.net/sec-filings/USPH/schedule-13g-a-u-s-physical-therapy-inc-nv-amended-passive-investment-e9d663b2ea7b.html
Vanguard Capital Management filed an amended Schedule 13G/A, reporting beneficial ownership of 720,170 common shares, or 4.82% of US Physical Therapy Inc. (USPH). The filing indicates Vanguard has sole voting power over 113,696 shares and sole dispositive power over all 720,170 shares, with zero shared voting or dispositive power. This ownership includes securities held across various Vanguard funds and client accounts.

US Physical Therapy (USPH) Stock Price, News & Analysis

https://www.stocktitan.net/overview/USPH/
This article provides an overview of US Physical Therapy (USPH), a national operator of outpatient physical therapy clinics and a provider of industrial injury prevention services. It details the company's business segments, financial performance, growth strategies through acquisitions, and its stock market position. The report also includes recent news, SEC filings, insider trading activity, and upcoming financial events for USPH.

USPH Q3'26 Earnings: revenue estimate is 214.48M USD

https://www.tradingview.com/news/tradingview:8e5300f56cc97:0-usph-q3-26-earnings-revenue-estimate-is-214-48m-usd/
U.S. Physical Therapy, Inc. (USPH) is scheduled to release its Q3'26 earnings on November 04, after the market closes, with disclosure expected at 4:00 PM ET. Analysts anticipate revenue to reach $214.48 million and earnings per share (EPS) to be $0.76 for the quarter. The article provides historical reported and estimated revenue and EPS figures, along with surprise percentages for previous quarters.
Advertisement

Why (USPH) Price Action Is Critical for Tactical Trading

https://news.stocktradersdaily.com/news_release/21/Why_USPH_Price_Action_Is_Critical_for_Tactical_Trading_102526024002_1792910402.html
This article analyzes U.s. Physical Therapy Inc. (NASDAQ: USPH) for tactical trading, highlighting its strong near and mid-term sentiment which could extend to the long term. It identifies no resistance levels above the current price, suggesting upside potential. The report provides AI-generated institutional trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis.

U.S. Physical Therapy, Inc. Estimates – LSX:923954

https://www.tradingview.com/symbols/LSX-923954/financials-estimates/?category=income_statement
This page provides financial actuals and analyst estimates for U.S. Physical Therapy, Inc. (LSX:923954), detailing income statement, balance sheet, cash flow, and valuation metrics. Users can compare actual results with average, high, and low estimates and visualize trends over time. The platform also includes a disclaimer stating that the information is not investment advice and encourages users to conduct their own research.

A physical therapy clinic operator schedules its results call for 10:30 a.m. ET Nov. 5.

https://www.stocktitan.net/news/USPH/u-s-physical-therapy-inc-schedules-third-quarter-2026-earnings-he452po8hmpr.html
U.S. Physical Therapy, Inc. (USPH) announced it will release its third-quarter 2026 financial results after the market closes on November 4, 2026. A conference call to discuss these results will follow on November 5, 2026, at 10:30 a.m. ET. The company operates 799 outpatient physical therapy clinics and provides industrial injury prevention services.

U.S. Physical Therapy, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call Dates

https://finance.yahoo.com/healthcare/articles/u-physical-therapy-inc-schedules-113000694.html
U.S. Physical Therapy, Inc. (USPH) announced it will release its financial results for the three and nine months ended September 30, 2026, on Wednesday, November 4, 2026, after market close. A conference call to discuss these results will follow on Thursday, November 5, 2026, at 10:30 am Eastern. Investors can access the call via dial-in or through the company's website.

U.S. Physical Therapy appoints Myra Davis before U.S. Physical Therapy stock results

https://www.ad-hoc-news.de/boerse/news/nebenwerte/u-s-physical-therapy-appoints-myra-davis-before-u-s-physical-therapy-stock-results/70353612
U.S. Physical Therapy (USPH) has appointed Myra Davis to its board, effective October 1, 2026, bringing significant technology and innovation experience to the company. This appointment precedes the release of the company's third-quarter results, scheduled for November 4, 2026. The company reported Q2 2026 revenue of $214.06 million, an 8.5% year-over-year increase, though profit margins faced pressure from healthcare claims and hiring costs.
Advertisement

U.S. Physical Therapy appoints Myra Davis before U.S. Physical Therapy stock results

https://www.ad-hoc-news.de/boerse/news/nebenwerte/u-s-physical-therapy-appoints-myra-davis-before-u-s-physical-therapy/70353612
U.S. Physical Therapy (USPH) has appointed Myra Davis to its board of directors, bringing significant healthcare technology experience to the company. This appointment comes as the company prepares to release its third-quarter results on November 4, 2026. While Q2 2026 revenue increased by 8.5% year-over-year to USD 214.06 million, the company experienced margin pressure, with adjusted physical therapy gross profit margin falling to 19.9%.

U.S. Physical Therapy appoints Myra Davis. U.S. Physical Therapy stock costs EUR 75.75

https://www.ad-hoc-news.de/boerse/news/nebenwerte/u-s-physical-therapy-appoints-myra-davis-u-s-physical-therapy-stock-costs-eur-75-75/70329290
U.S. Physical Therapy has appointed Myra Davis to its board of directors, effective October 1, 2026. Davis brings extensive technology and innovation expertise from her role at Texas Children's Hospital. The company also reported second-quarter revenue of USD 214.06 million, an 8.50 percent increase year-over-year, and reaffirmed its adjusted EBITDA guidance for fiscal year 2026.

Understanding Momentum Shifts in (USPH)

https://news.stocktradersdaily.com/news_release/141/Understanding_Momentum_Shifts_in_USPH_101426055801_1792015081.html
This article from Stock Traders Daily provides an AI-driven analysis of U.s. Physical Therapy Inc. (NASDAQ: USPH), highlighting a strong near-term sentiment but a neutral mid and long-term outlook. It identifies compelling upside potential due to a lack of resistance above the current price and offers three institutional trading strategies tailored to different risk profiles. The analysis includes multi-timeframe signal analysis, detailing support and resistance levels.

A passive investor reports 940,528 shares in U.S. Physical Therapy (USPH).

https://www.stocktitan.net/sec-filings/USPH/schedule-13g-u-s-physical-therapy-inc-nv-passive-investment-disclosur-e4c2154b99d7.html
Copeland Capital Management, LLC has reported a 6.3% passive stake in U.S. Physical Therapy (USPH), beneficially owning 940,528 common shares as of September 30, 2026. This Schedule 13G filing indicates the investment was made in the ordinary course of business, without the intent to influence company control. The filing details specific voting and dispositive powers held by Copeland over these shares.

U.S. Physical Therapy stock trades below EUR 74.00 and Davis joined its board

https://www.ad-hoc-news.de/boerse/news/nebenwerte/u-s-physical-therapy-stock-trades-below-eur-74-00-and-davis-joined-its/70264434
U.S. Physical Therapy (USPH) stock was trading at EUR 73.50 on October 8, 2026, below its prior close of EUR 74.00. The company announced Myra Davis joined its board, bringing technology and digital transformation expertise. Despite revenue growth of 8.50% in Q2 2026, the company faced margin pressure, with adjusted physical therapy gross margin falling to 19.90%.
Advertisement

U.S. Physical Therapy appoints Myra Davis: analysts target U.S. Physical Therapy stock at USD 98.25

https://www.ad-hoc-news.de/boerse/news/nebenwerte/u-s-physical-therapy-appoints-myra-davis-analysts-target-u-s-physical-therapy-stock-at-usd-98-25/70247801
U.S. Physical Therapy (USPH) has appointed Myra Davis to its board of directors, effective October 1, 2026, bringing her expertise in healthcare technology and governance. Analysts have set a consensus target price of USD 98.25 for USPH stock, which implies a 17.30% upside from its recent NYSE quote of USD 83.76. Despite an 8.5% increase in Q2 2026 revenue, net income attributable to shareholders decreased, indicating ongoing profit pressures for the company.

U.S. Physical Therapy appoints Myra Davis: analysts target U.S. Physical Therapy stock at USD 98.25

https://www.ad-hoc-news.de/boerse/news/nebenwerte/u-s-physical-therapy-appoints-myra-davis-analysts-target-u-s-physical/70247801
U.S. Physical Therapy (USPH) has appointed Myra Davis to its board, effective October 1, 2026, bringing her healthcare technology and governance expertise. Analysts have set a consensus target price of USD 98.25 for USPH stock, which implies a significant upside from its current market quote. The company reported an 8.50% increase in Q2 2026 revenue compared to the previous year, though net income and cash holdings saw a decline.

U.S. Physical Therapy stock reports 8.5 percent Q2 growth

https://www.ad-hoc-news.de/boerse/news/nebenwerte/u-s-physical-therapy-stock-reports-8-5-percent-q2-growth/70247933
U.S. Physical Therapy (USPH) reported an 8.5% increase in Q2 2026 revenue, reaching USD 214.1 million, driven by a 6.6% rise in clinic visits. Despite revenue growth, net income decreased to USD 9.9 million from USD 12.4 million in the prior-year quarter, leading to a weaker earnings per share. Analysts maintain a "Moderate Buy" consensus with an average target price of USD 98.25, suggesting an expected improvement beyond the current earnings figures.

USPH: Hospital Ties And Record Volumes Put Earnings At The Center

https://simplywall.st/community/narratives/us/healthcare/nyse-usph/us-physical-therapy/iginb3he-expanding-physical-therapy-demand-will-unlock-new-market-potential-7t2l/updates/12-the-thesis-on-us-physical-therapy-has-been-reviewed-and-re
U.S. Physical Therapy's earnings potential is now centered on record clinic volumes, hospital affiliations, and its Industrial Injury Prevention segment. The company's fair value has increased slightly to $97.00, driven by higher revenue growth assumptions, though net profit margins are expected to be marginally lower. The Industrial Injury Prevention segment is recognized as a significant earnings pillar, while previous expectations for supportive regulatory reimbursement have been dropped due to ongoing risks.

U.S. Physical Therapy stock reports 8.5 percent revenue growth

https://www.ad-hoc-news.de/boerse/news/corporate-news/u-s-physical-therapy-stock-reports-8-5-percent-revenue-growth/70231489
U.S. Physical Therapy (USPH) reported an 8.5% increase in Q2 2026 revenue to USD 214.1 million, though net income declined due to higher healthcare costs and hospital affiliation spending. Analysts maintain a "Moderate Buy" consensus with an average target price of USD 98.25. JPMorgan raised its target to USD 95.00, while the company focuses on integrating hospital relationships and expanding its physical therapy platform.
Advertisement

[Form 3] U S PHYSICAL THERAPY INC /NV Initial Statement of Beneficial Ownership

https://www.stocktitan.net/sec-filings/USPH/form-3-u-s-physical-therapy-inc-nv-initial-statement-of-beneficial-ow-38efba8ac5ac.html
This article reports on a Form 3 filing by U.S. Physical Therapy Inc. (USPH), an Initial Statement of Beneficial Ownership for Myra Davis. The SEC filing indicates that Myra Davis, a newly appointed Director, beneficially owns no securities in the company as of October 1, 2026. The document includes standard SEC Form 3 details and confirms Davis's role and address.

U.S. Physical Therapy, Inc. (USPH) Stock Price, News, Quote & History

https://ca.finance.yahoo.com/quote/USPH/
This article provides comprehensive financial information for U.S. Physical Therapy, Inc. (USPH), including its current stock price, historical performance, key financial metrics, and analyst ratings. It details the company's business operations in outpatient physical therapy and industrial injury prevention services, along with recent news and performance comparisons against the S&P 500.

U.S. Physical Therapy Hedges $170.6M Term Loan at 4.578% in SOFR Swap With Bank of America

https://www.tradingview.com/news/tradingview:38f9e7a081f2b:0-u-s-physical-therapy-hedges-170-6m-term-loan-at-4-578-in-sofr-swap-with-bank-of-america/
U.S. Physical Therapy entered into a forward-starting interest rate swap with Bank of America to hedge its $170.6 million term loan. This agreement, effective June 30, 2027, fixes monthly payments at 4.578% in exchange for one-month SOFR, aiming to stabilize borrowing costs and reduce interest rate risk until April 14, 2031. The transaction is governed by an existing ISDA Master Agreement.

Physitrack plc (PTRK) Launches AI EMR, Targets U.S. PT Clinics

https://www.tradingview.com/news/tradingview:8c4f4c1eee4d2:0-physitrack-plc-ptrk-launches-ai-emr-targets-u-s-pt-clinics/
Physitrack plc (PTRK) has launched an AI-powered Electronic Medical Record (EMR) system for U.S. physical therapy and rehabilitation practices, offering free early access with plans for paid subscriptions by January 2027. The system integrates with Claim.MD for billing and insurance claims, targeting solo and small practices in a fragmented market. This strategic move aims to expand Physitrack's market presence and customer engagement by transitioning from an adjunct tool to a core system of record.

Us Physical Therapy Stock Price Forecast. Should You Buy USPH?

https://stockinvest.us/stock/USPH
StockInvest.us has downgraded US Physical Therapy Inc (USPH) from a Strong Buy to a Hold/Accumulate rating, effective September 25, 2026. Despite the downgrade, the stock has shown a 5.37% gain since the hold signal on September 14, 2026, and is forecast to rise by 15.55% over the next three months. The analysis highlights several positive technical signals, including buy signals from both short and long-term moving averages and a recent Golden Star Signal, while also noting potential risks like falling volume on rising prices.
Advertisement

Technical Reactions to USPH Trends in Macro Strategies

https://news.stocktradersdaily.com/news_release/10/Technical_Reactions_to_USPH_Trends_in_Macro_Strategies_092426045601_1790240161.html
This article provides a technical analysis of U.s. Physical Therapy Inc. (NASDAQ: USPH), highlighting neutral near-term readings and potentially stalling strong mid-term sentiment. It outlines AI-generated trading strategies including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis for support and resistance levels. The report also mentions the availability of real-time trading signals and personalized analysis for registered users.

U.S. Physical Therapy, Inc. (USPH) stock price, news, quote and history

https://sg.finance.yahoo.com/quote/USPH/
This article provides comprehensive financial information for U.S. Physical Therapy, Inc. (USPH), including its current stock price, historical data, performance metrics against the S&P 500, and analyst insights. It details the company's operations in physical therapy and industrial injury prevention services. The report also highlights key financial figures such as market cap, P/E ratio, earnings trends, and analyst price targets.

Transcript: US Physical Therapy Q2 2026 Earnings Conference Call

https://www.benzinga.com/news/26/09/61861542/transcript-us-physical-therapy-q2-2026-earnings-conference-call
US Physical Therapy (NYSE: USPH) reported a strong Q2 2026 with an 8.5% revenue increase and record net rate per visit, driven by successful hospital affiliation arrangements, particularly with NYU Langone. The company addressed challenges like higher self-insured healthcare costs and front-loaded hiring expenses for partnerships, expecting these to be offset by continued WelcomeWare rollout and the full integration of hospital clinics. USPH reaffirmed its full-year 2026 adjusted EBITDA guidance, anticipating significant positive impact from ongoing hospital partnerships and future acquisitions.

U.S. Physical Therapy Adds Texas Children’s Technology Executive Myra Davis to Board

https://www.citybiz.co/article/906266/u-s-physical-therapy-adds-texas-childrens-technology-executive-myra-davis-to-board/
U.S. Physical Therapy, Inc. has appointed Myra Davis, a technology executive from Texas Children’s Hospital, to its Board of Directors. Davis brings extensive experience in healthcare technology, digital transformation, and information systems. Her appointment aims to strengthen the company's digital infrastructure as it manages a national network of 799 outpatient physical therapy clinics.

U.S. Physical Therapy Ahead on Addition to Board

http://www.baystreet.ca/articles/stockstowatch.aspx?articleid=124012
U.S. Physical Therapy, Inc. (NYSE: USPH) announced the appointment of Myra Davis to its Board of Directors, effective October 1. Davis, currently Executive Vice President and Chief Information Innovation Officer at Texas Children’s Hospital, brings over two decades of CIO-level healthcare leadership experience. Following the announcement, USPH shares saw a gain of 23 cents, closing at $82.70.
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement